Notice - Publication of the Guidance Document: Certificate of Supplementary Protection Regulations
September 19, 2017
Our reference number: 17-105997-499
Health Canada is pleased to announce the first publication of the Guidance Document: Certificate of Supplementary Protection Regulations.
As of September 21, 2017, the Office of Patented Medicines and Liaison, within the Office of Submissions and Intellectual Property, Therapeutic Products Directorate, will administer sections 104 to 134 of the Patent Act and the Certificate of Supplementary Protection Regulations.
The purpose of this Guidance Document is to outline the roles and responsibilities of applicants and the Therapeutic Products Directorate with respect to certificates of supplementary protection and applications.
Questions or concerns related to this Guidance Document should be directed to the Office of Patented Medicines and Liaison at:
Report a problem or mistake on this page
- Date modified: